Parab Swapnil, Gaikwad Sheetal, Majeti Saratchandra
Department of Anesthesiology, Critical Care and Pain, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Saudi J Anaesth. 2021 Jul-Sep;15(3):312-323. doi: 10.4103/sja.sja_1106_20. Epub 2021 Jun 19.
The anesthesia regimen used during one lung ventilation (OLV) carry the potential to affect intra-operative course and post-operative outcomes, by its effects on pulmonary vasculature and alveolar inflammation. This narrative review aims to understand the pathophysiology of acute lung injury during one lung ventilation, and to study the effects of inhalational versus intravenous anaesthetics on intraoperative and post-operative outcomes, following thoracic surgery. For this purpose, we independently searched 'PubMed', 'Google Scholar' and 'Cochrane Central' databases to find out randomized controlled trials (RCTs), in English language, which compared the effects of intravenous versus inhalational anaesthetics on intraoperative and post-operative outcomes, in elective thoracic surgeries, in human beings. In total, 38 RCTs were included in this review. Salient results of the review are- Propofol reduced intraoperative shunt and maintained better intraoperative oxygenation than inhalational agents. However, use of modern inhalational anaesthetics during OLV reduced alveolar inflammation significantly, as compared to propofol. Regarding post-operative complications, the evidence is not conclusive enough but slightly in favour of inhalational anaesthetics. Thus, we conclude that modern inhalational anaesthetics, by their virtue of better anti-inflammatory properties, exhibit lung protective effects and hence, seem to be safe for maintenance of anesthesia during OLV in elective thoracic surgeries. Further research is required to establish the safety of these agents with respect to long term post-operative outcomes like cancer recurrence.
单肺通气(OLV)期间使用的麻醉方案有可能通过其对肺血管系统和肺泡炎症的影响来影响术中过程和术后结果。本叙述性综述旨在了解单肺通气期间急性肺损伤的病理生理学,并研究吸入麻醉剂与静脉麻醉剂对胸外科手术后术中和术后结果的影响。为此,我们独立检索了“PubMed”、“谷歌学术”和“Cochrane中心”数据库,以查找英文的随机对照试验(RCT),这些试验比较了静脉麻醉剂与吸入麻醉剂对择期胸外科手术中人类术中和术后结果的影响。本综述共纳入38项RCT。该综述的主要结果是——与吸入麻醉剂相比,丙泊酚可减少术中分流并维持更好的术中氧合。然而,与丙泊酚相比,在OLV期间使用现代吸入麻醉剂可显著减轻肺泡炎症。关于术后并发症,证据不够确凿,但略倾向于吸入麻醉剂。因此,我们得出结论,现代吸入麻醉剂凭借其更好的抗炎特性,具有肺保护作用,因此,在择期胸外科手术的OLV期间维持麻醉似乎是安全的。需要进一步研究来确定这些药物在癌症复发等长期术后结果方面的安全性。